Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Drugs Influencing Immune Function > (-)-Pimecrolimus for Sale > Best Price USP 99% Pimecrolimus CAS:137071-32-0 for Atopic Dermatitis Treatment
Best Price USP 99% Pimecrolimus CAS:137071-32-0 for Atopic Dermatitis Treatment buy - large image1
Best Price USP 99% Pimecrolimus CAS:137071-32-0 for Atopic Dermatitis Treatment buy - image1
Best Price USP 99% Pimecrolimus CAS:137071-32-0 for Atopic Dermatitis Treatment buy - image2
Best Price USP 99% Pimecrolimus CAS:137071-32-0 for Atopic Dermatitis Treatment buy - image3
Best Price USP 99% Pimecrolimus CAS:137071-32-0 for Atopic Dermatitis Treatment buy - image4
Best Price USP 99% Pimecrolimus CAS:137071-32-0 for Atopic Dermatitis Treatment buy - image5
Best Price USP 99% Pimecrolimus CAS:137071-32-0 for Atopic Dermatitis Treatment buy - image6

Best Price USP 99% Pimecrolimus CAS:137071-32-0 for Atopic Dermatitis Treatment

TDS 5 Inquiries

Unit Price:

$150-180/G FOB

Get Latest Price
CAS No.:

137071-32-0

Grade:

Pharmaceutical Grade

Content:

99.9%

Port:

Hangzhou

Brand:

HyperChem

Packaging:

1kg/bag, 5kg/bag, 25kg/Drum

Price valid (until):

2027-02-28

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

  • Product Description

  • Seller Information

  • Inquiry History

  • Description
    Name Pimecrolimus
    CAS number 137071-32-0
    Synonym Pimecrolimus
    Elidel
    137071-32-0
    SDZ-ASM 981
    SDZ-ASM-981
    Description Pimecrolimus: A Comprehensive Overview

    Pimecrolimus (CAS: 1143-70-0) is a topical calcineurin inhibitor developed for the treatment of inflammatory skin conditions, particularly atopic dermatitis. This macrolactam derivative, marketed under the brand name Elidel, represents a significant advancement in dermatological therapy as the first non-steroidal cream approved in the United States for mild-to-moderate atopic dermatitis.

    Chemical Properties and Mechanism of Action
    Pimecrolimus selectively targets T cells and mast cells in the skin, exerting its anti-inflammatory effects through a unique mechanism. The compound binds to cytosolic immunophilin receptor macrophilin-12, forming a complex that inhibits the calcium/calmodulin-dependent phosphatase calcineurin. This inhibition blocks the dephosphorylation of nuclear factor of activated T cells (NFAT), preventing its translocation to the nucleus and subsequent transcription of inflammatory cytokines including interleukin-2 (IL-2), IL-4, interferon-gamma, and tumor necrosis factor-alpha. Unlike corticosteroids, pimecrolimus does not affect endothelial cells or fibroblasts and does not induce skin atrophy, making it particularly suitable for sensitive areas such as the face and intertriginous regions.
    Clinical Applications

    FDA-Approved Indications
    Pimecrolimus cream 1% is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adults and children 2 years of age and older who have failed to respond adequately to other topical prescription treatments or when those treatments are not advisable.

    Off-Label Uses

    Beyond atopic dermatitis, pimecrolimus has demonstrated efficacy in several other inflammatory skin conditions:
    Seborrheic dermatitis of the face and trunk
    Intertriginous psoriasis
    Facial and inverse psoriasis
    Oral and genital lichen planus
    Perioral dermatitis
    Cutaneous lupus erythematosus
    Cutaneous chronic graft-versus-host disease.

    Efficacy and Clinical Evidence
    Multiple randomized controlled trials have established the efficacy of pimecrolimus in atopic dermatitis management. In a 5-year open-label study involving 2,418 infants, pimecrolimus demonstrated rapid onset of action with over 50% of patients achieving treatment success by week 3. After 5 years, more than 85% of patients achieved overall treatment success, with the pimecrolimus group requiring substantially fewer steroid days compared to the topical corticosteroid group (7 vs 178 days). The study concluded that long-term management with pimecrolimus was safe without any effect on the immune system.
    For seborrheic dermatitis, clinical trials have shown that pimecrolimus applied twice daily significantly improves erythema and scaling scores. In a randomized, double-blind study of 96 adults with moderate to severe facial seborrheic dermatitis, pimecrolimus demonstrated superiority over vehicle as early as week 2, with significant differences observed in per-protocol analysis.

    Pharmacokinetics and Safety Profile
    Systemic Absorption
    Pimecrolimus exhibits minimal systemic absorption when applied topically, with blood levels remaining very low. This low systemic exposure contributes to its favorable safety profile. The compound is extensively bound to plasma proteins (99.6%) and undergoes hepatic metabolism primarily via CYP3A4 enzymes. Elimination occurs predominantly through fecal excretion (78.4%), with only 2.5% excreted in urine.
    Side Effects
    The most common adverse effects are local application site reactions, including burning, stinging, or pruritus, which typically occur during the first few days of treatment and improve with continued use. Other reported side effects include headache, nasopharyngitis, pyrexia, and upper respiratory tract infections. These effects are generally mild to moderate and transient.

    Safety Considerations
    Pimecrolimus carries a black-box warning regarding the theoretical risk of malignancy based on animal studies and post-transplant patients receiving systemic calcineurin inhibitors. However, clinical data from topical use have not established a causal relationship between pimecrolimus and increased risk of skin malignancies or lymphomas. Continuous long-term use should be avoided, and application should be limited to affected areas only.
    Clinical Evaluation and Patient Management
    Pimecrolimus is applied as a thin layer to affected skin twice daily, with treatment discontinued when signs and symptoms resolve. If dermatitis does not improve within 6 weeks, patients should be re-evaluated to confirm diagnosis. The medication should not be used under occlusive dressings, and its safety has not been established beyond 1 year of non-continuous use.

    Comparative Advantages
    Compared to topical corticosteroids, pimecrolimus offers several advantages:
    No risk of skin atrophy, telangiectasias, or striae
    Suitable for use on sensitive areas (face, eyelids, intertriginous regions)
    Can be used as a steroid-sparing agent in long-term management
    Minimal systemic absorption and side effects

    Conclusion
    Pimecrolimus represents an important therapeutic option in the management of inflammatory skin diseases, particularly atopic dermatitis. Its selective mechanism of action, favorable safety profile, and efficacy in both acute treatment and long-term maintenance make it a valuable addition to the dermatological armamentarium. While appropriate precautions should be taken regarding long-term use and potential theoretical risks, clinical evidence supports its role as an effective and well-tolerated treatment for patients who cannot use or have failed conventional therapies.
     
    Molecular Formula C 43 H 68 ClNO 11
    Molecular Weight 810.4 g/mol
    Appearance White or almost white crystalline powder
    Quality Standard USP EP
    Shipping Condition Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
    Storage Condition Dry, dark and at room temperature for short term (days to weeks) or -20 for long term (months to years).
    Shelf Life >2 years if stored properly
    Sample package Aluminium foil bag
    Commercial package Fiber drum
    Origin China


    Product Image

    Shop USP Quality Standard API Finasteride Powder with CAS 98319-26-7-Detailed Image 2

    Shop USP Quality Standard API Finasteride Powder with CAS 98319-26-7-Detailed Image 3



    FAQ

    Q1. What is the Hyper chem payment term?
    T/T advance
    LC at sight
    DP at sight
    Trade assurance 
    Money gram 


    Q2. What is Hyper chem shipment policy?
    Our policy is to strive for the quickest shipment time possible, with ready stock sample shipment typically going out the same day that your order was placed. Your satisfaction is very important to us.
    For non-ready stock, please contact the Hyper Chem sales team to negotiate.

     

    Q3. What hyper chem will provide after shipment?
    For sample orders: 
    After shipment is done, an timely email including:

    Track details (Fedex /TNT/DHL/EMS Track number)

    Package photo

    COA, MSDS, etc 

    Dispatch date & Estimated arriving time

    Shipping invoice

    For commercial orders
    A full set of shipment documents as well as package photos can be provided
    in scan-copy and original, to help customers complete the customs clearance process.

     

    Q4. What is Hyper Chem shipment term?

               By Express   
    DHL  FedEx  TNT  EMS                               
    Fast:5 days around                             
    High cost, door to door service

               By Air                                        
    Suitable for more than 50kg 
    Fast :3-7 days Hight cost, port to port, professional broker needed 

               By Sea
    Suitable for more than 500kg      
    Slow:7-45 days, Low cost, port to port, professional broker needed 
    We will always attempt to utilize the quickest and most affordable way for customers to receive orders. And follow -up with customers via email for all shipment details as well as updated track information until it arrives without damage.

     

    Q5. Does hyper chem provide a shipment return policy?
    Yes, we have.
    Return Policy:  At Hyper chem, your satisfaction is guaranteed. If you are dissatisfied for any reason with a product, please send back the unused portion along with your packing slip and a brief note on why you were dissatisfied  within 45 days of purchase for a full refund to:

     

    Q6. What is hyper chem After-sales service
    •Documents support: COA ,MSDS, MOA ,MS Report,HNMR Report,SDS,DMF
    • Customer Support: Shipment clearance support, quality issue support
    • Automated Customer Service: Our worldwide customers enjoy immediate 24/7 access to the HYPER CHEM support team from any location, at any time.

     

     

     

    Company profile

    Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to cater to the requirements of our diverse range of clients.

     

    Among them, our key client industrial sectors around the global are:

     

    Pharmaceuticals
    Nutrition Ingredients/ Dietary supplements
    Cosmetic Ingredients
    Food Ingredients
    Veterinary API
    Agriculture fertilizer
    Custom Synthesis lab supply

     

    HyperChem provides to its wonderful and honorable clients comprehensive purchasing and distribution services which ensure that we are delivering the right generic, raw, or customized product, make sure that we are delivering it at the right time, ensure that it is delivered in the specified amount, and in the right kind of packaging to clients and customers of all types of industries irrespective of their size of operation.


    Certificates

    Basic Info
    Product Name:

    (-)-Pimecrolimus

    Other Name:

    15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,3-[(1E)-2-[(1R,3R,4S)-4-chloro-3-methoxycyclohexyl]-1-methylethenyl]-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-,(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-;15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone,3-[2-(4-chloro-3-methoxycyclohexyl)-1-methylethenyl]-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-,[3S-[3R*[E(1S*,3S*,4R*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-;(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-3-[(1E)-2-[(1R,3R,4S)-4-Chloro-3-methoxycyclohexyl]-1-methylethenyl]-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone;33-epi-Chloro-33-desoxyascomycin;SDZ-ASM 981;Pimecrolimus;Elidel;ASM 981;33-Epichloro-33-desoxyascomycin;Picrolimus;(-)-Pimecrolimus

    CAS No.:

    137071-32-0

    Molecular Formula:

    C43H68ClNO11

    InChIKeys:

    InChIKey=KASDHRXLYQOAKZ-XDSKOBMDSA-N

    Molecular Weight:

    810.459

    Exact Mass:

    810.45

    EC Number:

    1308068-626-2

    DSSTox ID:

    DTXSID2046674

    ATC Code:

    D - Dermatologicals

    Characteristics
    PSA:

    158.13000

    XLogP3:

    5.65730

    Appearance:

    white crystalline powder

    Density:

    1.2±0.1 g/cm3

    Melting Point:

    135-136 °C

    Boiling Point:

    866.1°C at 760 mmHg

    Flash Point:

    477.6±37.1 °C

    Refractive Index:

    1.543

    Storage Conditions:

    -20°C Freezer

    Vapor Pressure:

    5.44E-35mmHg at 25°C

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 4, Oral

    Acute toxicity - Category 4, Dermal

    Acute toxicity - Category 4, Inhalation

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H302 Harmful if swallowed

    H312 Harmful in contact with skin

    H332 Harmful if inhaled

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P261 Avoid breathing dust/fume/gas/mist/vapours/spray.

    P271 Use only outdoors or in a well-ventilated area.

    Response

    P301+P317 IF SWALLOWED: Get medical help.

    P330 Rinse mouth.

    P302+P352 IF ON SKIN: Wash with plenty of water/...

    P317 Get medical help.

    P321 Specific treatment (see ... on this label).

    P362+P364 Take off contaminated clothing and wash it before reuse.

    P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

    Location:

    Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    10

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2013

    Certifications:

    Certification Report by Bureau Veritas

    About HyperChem

    Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to meet the needs of a diverse range of pharmaceutical cosmetics ingredients and nootropic supplements companies worldwide.

    Our Competitiveness

    One-stop supply

    Wide Range Of products including pharmaceutical, Cosmetic Ingredients and nootropic supplements

    Among all the pharmaceuticals,

    90% of them with GMP certificates,

    85% of them with DMF files and

    50% of them passed FDA approval,

    30% get CEP certificate

    20% are new R&D products.

    Custom Repackaging Service


    We can efficiently repackage your material into sample sizes, custom batch-specific sizes, or semi-bulk package sizes according to your specifications. And ensures the product is packaged in a quality-controlled environment and will maintain its integrity throughout every stage of the process.

    Quality Control/Quality Assurance


    HyperChem is committed to delivering on its promises of top-quality products with verified quality data.

    All materials are vigorously inspected by the factory and/or outsourced analytical laboratories to ensure each and every lot meets or exceeds our reference standards.

    Trade assurance service with 100% payment protection, It is best achieved by delivering products and services 100% right the first time, on time, every time.

    Professional

    Transparent Communication

    Fast Reaction,

    Professional Suggestion

    Beyond Expectation.

    We have exclusive partnerships with research and production facilities across the country and we offer varied pharmaceutical services in the most cost-efficient way. The production facilities are GMP, WHO-GMP, EU GMP and US FDA approved and are backed by strong regulatory support such as Dossier, DMF, Tech Pack and relevant Stability studies for regulatory filings.

  • Inquiry History
    5 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Pimecrolimus 99% white

    2 G Sep 16, 2023
    Pakistan

    PIMECROLIMUS

    0.5 KG Mar 24, 2026
    Pakistan

    pimecrolimus

    128 G Jan 7, 2026
    Pakistan

    PIMECROLIMUS

    500 G May 8, 2024
    Pakistan

    PIMECROLIMUS

    500 G May 7, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.